Milestone Pharmaceuticals Inc.
MIST· Nasdaq
Released Mar 6, 2020, before the open
10-K filed Mar 6, 2020, 66 days after period end · 0001558370-20-002106
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|
| Net Income | -$18.29M | -$9.72M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 6, 2020 · 66 d after period end
+5.2% from the close of Mar 2, 2020 to the close of Mar 9, 2020, the first after the release.